RecruitingNCT04295252
Altshock-2 REGISTRY
Cardiogenic Shock: a Prospective National Registry to Get Insights in Patients' Profile, Management and Outcome
Sponsor
Niguarda Hospital
Enrollment
3,000 participants
Start Date
Jul 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- All consecutive CS patients hospitalized in the above reported centres between January 2020 and December 2030.
- Cardiogenic shock is defined as:
- Systolic blood pressure (SBP) <90 mmHg or mean arterial pressure (MAP) <60 mmHg, after an appropriate fluid challenge if there is no sign of overt fluid overload, OR need of vasoactive agents to maintain SBP > 90 mmHg or MAP > 60 mmHg, OR need of MCS;
- At least one of the following criteria/signs of overt hypoperfusion: mixed venous oxygen saturation <60%; arterial lactates > 2 mmol/L; oliguria < 0.5 ml/Kg/h for at least 6 hours.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04295252
Related Trials
Physiology of Unloading VA ECMO Trial
NCT063366551 location
Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock
NCT066382681 location
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
NCT075271561 location
Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock
NCT0734555911 locations
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
NCT075155084 locations